Table 3.
ASMs tested in the apoptotic model.
Data on Risks | Unknown Risks | |
---|---|---|
Higher Risks | Acetazolamide | Lorazepam |
Clonazepam | Briviracetam | Midazolam |
Diazepam | Cannabidiol | Oxcarbazepine |
Phenobarbital | Cenobamate | Perampanel |
Phenytoin | Clobazam | Pregabalin |
Valproate | Diazepam | Primidone |
Vigabatrin | Eslicarbazepine | Rufinamide |
Ethosuximide | Stiripentol | |
Lower Risks | Everolimus | Sulthiame |
Carbamazepine | Felbamate | Tiagabine |
Lamotrigine | Fenfluramine | Zonisamide |
Levetiracetam | Gabapentin | |
Topiramate | Lacosamide |
Note that the model is predictive of effects in humans, but does not explore all possible mechanisms.
ASMs = antiseizure medications.